[1]
F. Mennini, S. Russo, and A. Marcellusi, “Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy”, FE, vol. 13, no. 3, pp. 121–131, Sep. 2012.